Daiichi Sankyo Co Ltd

JP

DASCO

Health Care

30.12 ₽

Current price

Strong buy
30.12 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    127 / 1328

  • Position in country

    1033 / 4811

  • Net income margin, %

    15

    2.8

  • EBITDA margin, %

    25.6

    10.8

  • Debt to Equity, %

    6.4

    19.2

  • Intangible assets and goodwill, %

    7.6

    3.6

  • P/BV

    5.5

    1.5

  • EV/EBITDA

    48.4

    7.4

  • Average Analyst recommendation

    Buy

    Buy

  • Average upside forecasts, %

    29.5

    51.3

  • Forward P/E

    47

    15.6

  • Dividend Yield, %

    0.8

    1.7

  • Forward Dividend Yield, %

    1.2

    0.2

  • Expected dividend per share

    0.3

    0

  • Payout Ratio, %

    36.1

    30.3

Get an analytical review of this company

Competitors

Ranks

  • Daiichi Sankyo Co Ltd

    00%

  • Ono Pharmaceutical Co Ltd

    00%

  • Kyowa Kirin Co Ltd

    00%

  • Shionogi & Co Ltd

    00%

  • Taisho Pharmaceutical Holdings Co Ltd

    00%

  • Chugai Pharmaceutical Co Ltd

    00%

  • Takeda Pharmaceutical Co Ltd

    00%

  • Eisai Co Ltd

    00%

  • Otsuka Holdings Co Ltd

    00%

  • Astellas Pharma Inc

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    Japan

  • Sector

    Health Care

  • Industry group

    Pharmaceuticals, Biotechnology & Life Sciences

  • Industry

    Pharmaceuticals

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    58841.6

  • Ticker

    DSNKY.PK

  • ISIN

    US23381D1028

  • IPO date

    2005-09-28

  • Availability on Russian exchanges

    No

  • Reporting for

    2024-02-06

  • Date fact. publication of reports

    2023-12-31

Company Description

Daiichi Sankyo Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of pharmaceuticals. The Company is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The Company is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.

A step towards better analytics

  • find the best promotions through the Screener
  • keep an eye on stock valuation
  • download detailed reports

and much more after free registration

Registration

More convenient from your phone? Download: